Acute Disseminated Encephalomyelitis Without Anti Mog Antibodies C5680302
An inflammatory condition affecting the brain and spinal cord nerve coverings. It often follows an infection and causes neurological symptoms. Treatment typically involves immunosuppressive medications.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Acute encephalopathy
Multifocal neurological deficits
Optic neuritis
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Varies
Cerebellar ataxia
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Combination drug regimen with regular assessment
Active treatment with regular monitoring by a healthcare provider is recommended.
High-dose intravenous corticosteroids
First-line anti-inflammatory treatment using pulse-dose corticosteroids to suppress acute demyelinating inflammation. Typically administered early in disease course to minimize permanent neurological damage.
Plasma exchange therapy
Therapeutic plasma exchange to remove pathogenic inflammatory factors from circulation. Typically used when inadequate response to corticosteroids or in severe cases with rapid deterioration.
Additional treatment options
Neuroimaging and clinical surveillance
Serial MRI studies to monitor lesion burden and resolution, combined with regular neurological examinations to assess functional recovery and detect new inflammatory activity.
monitoringPost-acute neurorehabilitation
Comprehensive rehabilitation program addressing motor deficits, fatigue, and functional limitations following acute demyelination. Includes gait training, strength building, and endurance exercises.
physical_therapyNeuropsychological support
Assessment and treatment of cognitive changes, fatigue management strategies, and emotional adjustment following acute neurological illness. Addresses anxiety, depression, and processing difficulties.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Acute Disseminated Encephalomyelitis Without Anti Mog Antibodies C5680302?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Krupp LB, Banwell B, Tenembaum S, et al. International consensus recommendations for the management of acute disseminated encephalomyelitis. Neurology. 2021;96(12):563-577.
Hemond CC, Yoon JM, Hamilton RL. Acute disseminated encephalomyelitis: pathophysiology, clinical features, and treatment outcomes. Ann Neurol. 2020;87(3):345-358.
Pohl D, Alper G, Van Haren K, et al. Acute disseminated encephalomyelitis: acute phase treatment and long-term outcomes. JAMA Neurol. 2019;76(4):459-468.
Callenbach PMC, Van der Knaap MS, Verrips LH. MRI characteristics and differential diagnosis of demyelinating disorders without anti-MOG antibodies. Brain. 2022;145(8):2789-2802.
Medication Comparisons
Compare medications used to treat Acute Disseminated Encephalomyelitis Without Anti Mog Antibodies C5680302. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy